Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386083642> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4386083642 abstract "To improve patient outcomes in the otherwise incurable hematologic malignancy of multiple myeloma (MM), a key paradigm includes initial treatment to establish disease control rapidly followed by maintenance therapy to ensure durability of response with manageable toxicity. However, patient prognosis becomes worse after relapse, and the disease burden and drug toxicities are generally more challenging with subsequent lines of therapy. It is therefore particularly important that patients with newly diagnosed multiple myeloma (NDMM) receive optimal frontline therapy. The combination of lenalidomide, bortezomib, and dexamethasone (RVd) has consistently demonstrated a tolerable safety profile with significant and clinically relevant benefit, including deep and durable responses with improved survival in patients with NDMM regardless of their transplant eligibility. Furthermore, comparative studies evaluating this triplet against both doublets and other triplet regimens have established RVd as a standard of care in this setting based upon its remarkable and concordant efficacy. Given the breadth of clinical data, physician familiarity, inclusion in treatment guidelines, and the emerging potential of RVd-containing quadruplet regimens, RVd will likely continue as a key cornerstone of NDMM therapy, and its role will therefore likely continue to grow as a therapeutic backbone in the initial treatment of MM." @default.
- W4386083642 created "2023-08-24" @default.
- W4386083642 creator A5000308170 @default.
- W4386083642 creator A5012186826 @default.
- W4386083642 creator A5015898454 @default.
- W4386083642 creator A5023276777 @default.
- W4386083642 creator A5026109406 @default.
- W4386083642 creator A5026574827 @default.
- W4386083642 creator A5029159537 @default.
- W4386083642 creator A5031837957 @default.
- W4386083642 creator A5032464400 @default.
- W4386083642 creator A5043526996 @default.
- W4386083642 creator A5045330640 @default.
- W4386083642 creator A5049711954 @default.
- W4386083642 creator A5052048627 @default.
- W4386083642 creator A5055832458 @default.
- W4386083642 creator A5069449708 @default.
- W4386083642 creator A5071438752 @default.
- W4386083642 creator A5071589084 @default.
- W4386083642 creator A5082698003 @default.
- W4386083642 date "2023-08-24" @default.
- W4386083642 modified "2023-10-03" @default.
- W4386083642 title "Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma" @default.
- W4386083642 doi "https://doi.org/10.3324/haematol.2022.282624" @default.
- W4386083642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37608773" @default.
- W4386083642 hasPublicationYear "2023" @default.
- W4386083642 type Work @default.
- W4386083642 citedByCount "0" @default.
- W4386083642 crossrefType "journal-article" @default.
- W4386083642 hasAuthorship W4386083642A5000308170 @default.
- W4386083642 hasAuthorship W4386083642A5012186826 @default.
- W4386083642 hasAuthorship W4386083642A5015898454 @default.
- W4386083642 hasAuthorship W4386083642A5023276777 @default.
- W4386083642 hasAuthorship W4386083642A5026109406 @default.
- W4386083642 hasAuthorship W4386083642A5026574827 @default.
- W4386083642 hasAuthorship W4386083642A5029159537 @default.
- W4386083642 hasAuthorship W4386083642A5031837957 @default.
- W4386083642 hasAuthorship W4386083642A5032464400 @default.
- W4386083642 hasAuthorship W4386083642A5043526996 @default.
- W4386083642 hasAuthorship W4386083642A5045330640 @default.
- W4386083642 hasAuthorship W4386083642A5049711954 @default.
- W4386083642 hasAuthorship W4386083642A5052048627 @default.
- W4386083642 hasAuthorship W4386083642A5055832458 @default.
- W4386083642 hasAuthorship W4386083642A5069449708 @default.
- W4386083642 hasAuthorship W4386083642A5071438752 @default.
- W4386083642 hasAuthorship W4386083642A5071589084 @default.
- W4386083642 hasAuthorship W4386083642A5082698003 @default.
- W4386083642 hasBestOaLocation W43860836421 @default.
- W4386083642 hasConcept C126322002 @default.
- W4386083642 hasConcept C141071460 @default.
- W4386083642 hasConcept C143998085 @default.
- W4386083642 hasConcept C177713679 @default.
- W4386083642 hasConcept C2776063141 @default.
- W4386083642 hasConcept C2776364478 @default.
- W4386083642 hasConcept C2777478702 @default.
- W4386083642 hasConcept C2779134260 @default.
- W4386083642 hasConcept C2780401358 @default.
- W4386083642 hasConcept C71924100 @default.
- W4386083642 hasConceptScore W4386083642C126322002 @default.
- W4386083642 hasConceptScore W4386083642C141071460 @default.
- W4386083642 hasConceptScore W4386083642C143998085 @default.
- W4386083642 hasConceptScore W4386083642C177713679 @default.
- W4386083642 hasConceptScore W4386083642C2776063141 @default.
- W4386083642 hasConceptScore W4386083642C2776364478 @default.
- W4386083642 hasConceptScore W4386083642C2777478702 @default.
- W4386083642 hasConceptScore W4386083642C2779134260 @default.
- W4386083642 hasConceptScore W4386083642C2780401358 @default.
- W4386083642 hasConceptScore W4386083642C71924100 @default.
- W4386083642 hasLocation W43860836421 @default.
- W4386083642 hasLocation W43860836422 @default.
- W4386083642 hasOpenAccess W4386083642 @default.
- W4386083642 hasPrimaryLocation W43860836421 @default.
- W4386083642 hasRelatedWork W14748329 @default.
- W4386083642 hasRelatedWork W1699374300 @default.
- W4386083642 hasRelatedWork W1988784378 @default.
- W4386083642 hasRelatedWork W1996748901 @default.
- W4386083642 hasRelatedWork W2192430028 @default.
- W4386083642 hasRelatedWork W2330049167 @default.
- W4386083642 hasRelatedWork W2983267579 @default.
- W4386083642 hasRelatedWork W3134875278 @default.
- W4386083642 hasRelatedWork W3217566318 @default.
- W4386083642 hasRelatedWork W2309095625 @default.
- W4386083642 isParatext "false" @default.
- W4386083642 isRetracted "false" @default.
- W4386083642 workType "article" @default.